Petersen Floyd F.'s Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Feb 2, 2024
- Accession no.
- 0001104659-24-010255
- Filed
- Feb 2, 2024
- Trade date
- Feb 1, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $26.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Petersen Floyd F.CIK 0001611286 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Common Stock | SSaleDisposed | −474 | $53.07 | −$25,155.18 | 80,359 | Direct | |
| Feb 1, 2024 | Common Stock | SSaleDisposed | −26 | $53.64 | −$1,394.64 | 80,333 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.